Sarcoidosis natural history, complications and prognosis: Difference between revisions
mNo edit summary |
|||
| Line 7: | Line 7: | ||
==Natural History== | ==Natural History== | ||
The overall mortality in [[sarcoidosis]] is low (about 5%), and many patients with spontaneous regression will never require treatment<ref>Gerke AK: Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med 20:472–478, 2014.</ref>. In people who need treatment, important differences exist between African-American and white patients. African-American patients with [[sarcoidosis]] experience a more severe and systemic disease and 12 times higher mortality <ref>Mirsaeidi M, et al: Racial difference in sarcoidosis mortality in the United States. Chest 147:438–449, 2015.</ref> | |||
==Complications== | ==Complications== | ||
Revision as of 20:31, 10 May 2018
|
Sarcoidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sarcoidosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Sarcoidosis natural history, complications and prognosis |
|
FDA on Sarcoidosis natural history, complications and prognosis |
|
CDC on Sarcoidosis natural history, complications and prognosis |
|
Sarcoidosis natural history, complications and prognosis in the news |
|
Blogs on Sarcoidosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Sarcoidosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Natural History
The overall mortality in sarcoidosis is low (about 5%), and many patients with spontaneous regression will never require treatment[1]. In people who need treatment, important differences exist between African-American and white patients. African-American patients with sarcoidosis experience a more severe and systemic disease and 12 times higher mortality [2]